• Plot No-208, Industrial Area, Phase 1, Panchkula-134113
  • 9371300000
  • novalab07777@gmail.com
  • Home
  • About Us
    • Company Profile
    • Vision & Mission
  • Franchise
  • Products Range
  • Divisions
    • CARDIC & DIABETIC
    • NOVALAB CAP & TAB
    • NOVALAB CRITICAL CARE
    • NOVALAB GYNAE CARE
    • NOVALAB PED & SYP
    • NOVALAB EYE VISION
    • CONIAK LIFESCIENCES
    • GREEK DERMA
    • NOVA VEDIC
    • DAZZLE HEALTHCARE
  • Our Policy
    • Quality Policy
    • Health & Safety Policy
    • Environmental Policy
  • Blogs
  • Contact Us

  • Home
  • CARDIAC/DIABETIC PRODUCTS
  • Voglibose Tablets  
CONIVOG 0.3

Voglibose Tablets  

CONIVOG-0.3

Category: CARDIAC/DIABETIC PRODUCTS

Enquiry about Voglibose Tablets  

Share
0
Description

Voglibose tablets  0.3mg is a type 2 diabetes mellitus medicine. It belongs to a class of medications known as alpha-glucosidase inhibitors. The tablet slows carbohydrate digestion and absorption by blocking specific enzymes in the colon, lowering blood sugar levels after meals. This aids in the management of postprandial (after-meal) glucose increases. To maximize its effectiveness, it is usually taken with food. Abdominal discomfort, gas, and diarrhea are common side effects. While taking Voglibose tablets or any other medicine, it is critical to adhere to the recommended dosage and see a healthcare expert for personalized guidance and monitoring.

How to Use Voglibose Tablets   

Voglibose tablets  0.3mg are often administered orally with meals. Your healthcare practitioner will determine the dosage and frequency depending on your particular needs and response to the drug. It is critical to properly follow the directions. Swallow the tablet whole, without crushing or chewing it, with a glass of water. It is critical to take the dose soon before or with the first bite of a meal. This allows the drug to operate properly by suppressing the carbohydrate-digesting enzymes. Maintaining a nutritious diet and a regular exercise routine can also help in managing diabetes. Blood sugar levels must be monitored regularly for best regulation.

How Do Voglibose Tablets Work?

Voglibose tablets acts by suppressing the function of alpha-glucosidases, which are enzymes found in the small intestine. These enzymes are in charge of converting complicated carbs into simpler sugars that may then be taken into the bloodstream. Voglibose tablets delay the digestion and absorption of carbohydrates, particularly complex sugars like starch and disaccharides, by blocking these enzymes.

Because of the delayed carbohydrate absorption, postprandial (after-meal) blood sugar levels are lower. Voglibose tablets help to reduce blood glucose rises after meals by reducing postprandial hyperglycemia. It should be noted that Voglibose tablets do not promote insulin synthesis or improve the efficacy of insulin that is already present in the body.

It should be noted that Voglibose tablets do not promote insulin synthesis or improve the efficacy of insulin that is already present in the body. Instead, it largely regulates glucose digestion and absorption, assisting in the control of type 2 diabetes mellitus.

Benefits of Using Voglibose Tablets

Voglibose tablets have various advantages in the treatment of type 2 diabetes mellitus. For starters, it lowers postprandial (after-meal) blood sugar levels by decreasing carbohydrate digestion and absorption. This lowers the danger of post-meal glucose rises, which are harmful to diabetics. Second, by managing blood sugar levels, Voglibose tablets contribute to overall glycemic control, which is critical for avoiding long-term diabetic problems. Furthermore, Voglibose tablets are well tolerated and have a low risk of hypoglycemia (low blood sugar). To achieve optimal glycemic control, it can be used as a monotherapy or in conjunction with other anti-diabetic drugs. However, it is critical to seek personalized advice from a healthcare practitioner regarding its use and any negative effects.

Uses of Voglibose tablets

Voglibose tablets are primarily used to treat type 2 diabetes mellitus. It’s used to assist regulate blood sugar levels, especially after meals. Voglibose tablets delay carbohydrate absorption by blocking the enzymes responsible for carbohydrate breakdown in the small intestine, resulting in a reduction in postprandial glucose spikes. This contributes to more consistent blood sugar levels throughout the day. Voglibose tablets are frequently used in conjunction with dietary and activity adjustments to improve glycemic control. Depending on the individual’s needs, it can be taken as a monotherapy or in combination with other anti-diabetic drugs. The goal is to establish and maintain excellent blood sugar control to avoid diabetic complications.

Precautions While Using Voglibose Tablets

Certain measures must be taken when using Voglibose tablets to guarantee safe and efficient usage of the medicine. Here are some important precautions to take:

  1. Inform your doctor about any current medical illnesses, such as renal or liver disease, digestive abnormalities, or intestinal blockage.
  2. Discuss with your doctor any other drugs, vitamins, or herbal remedies you are using because they may interact with Voglibose tablets.
  3. Follow the dosage and time recommendations. Do not exceed or skip doses without first seeing your doctor.
  4. Recognize the symptoms of hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar). Regularly check your blood sugar levels.
  5. To get the most out of Voglibose tablets, take them with meals as directed.
  6. Be cautious if you have a history of digestive issues, as Voglibose tablets may aggravate them.
  7. Notify your healthcare practitioner right away if you have any unusual or severe side effects.

Side Effects of Voglibose Tablets

Voglibose tablets, like any medicine, may cause negative effects. Abdominal discomfort, flatulence (excess gas), diarrhea, and bloating are common adverse effects. The medication’s mechanism of slowing carbohydrate digestion causes these gastrointestinal symptoms. Voglibose tablets can cause low blood sugar levels (hypoglycemia) in some people, especially when coupled with other diabetes treatments. Allergic reactions, liver issues, and abnormal blood counts have been recorded infrequently. It is critical to notify your healthcare professional as soon as possible if you have any severe or persistent adverse effects. They can advise you on how to manage adverse effects and, if necessary, change the medicine dosage.

Additional information
Composition

Voglibose 0.3mg

Pack Type

10×10

Related products

  • Torsemide Tablets

  • Placeholder

    Torsemide & Spironolactone Tablets

  • Amlodipine & Atenolol Tablets

Product categories

  • CARDIAC/DIABETIC PRODUCTS
  • DERMA PRODUCTS
  • EYE /EAR & NASAL DROPS
  • GENERAL PRODUCTS
  • INFUSION SECTION
  • INJECTION
  • OTHER PRODUCTS
  • PAEDIATRIC DROP
  • PAEDIATRIC DRY SYRUP
  • PROTEIN POWDER
  • SYRUP/SUSPENSION
  • TABLETS / CAPSULES / SOFT GEL

Contact us

Novalab Healthcare

We are a research-based pharmaceutical company. The mission of Novalab Healthcare is to improve the health of the Indian community by providing them with quality

Quick Links
  • Home
  • About Us
  • Franchise
  • Products Range
  • Our Policy
  • Contact Us
Location
  • Plot No-208, Industrial Area Phase 1, Panchkula, Haryana 134113
  • Novalab7777@gmail.com
  • +91-9570599567
  • +91-9115604598
Map
Copyright by © 2025 Novalab Healthcare | Web Development and Marketing By Web Hopers